Track market-moving stories before they get noisy

Albemarle (ALB - Free Report) ended the recent trading session at $114.85, demonstrating a -1.76% change from the preceding day's closing price. This change lagged the S&P 500's 0.05% gain on the day. Elsewhere, the Dow saw an upswing of 0.46%, while the tech-heavy Nasdaq depreciated by 0.64%.

Coming into today, shares of the specialty chemicals company had lost 17.11% in the past month. In that same time, the Basic Materials sector lost 1.68%, while the S&P 500 gained 0.61%.

The investment community will be closely monitoring the performance of Albemarle in its forthcoming earnings report. The company is scheduled to release its earnings on August 5, 2026. The company is expected to report EPS of $3.39, up 2981.82% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $1.53 billion, reflecting a 15.04% rise from the equivalent quarter last year.

For the annual period, the Zacks Consensus Estimates anticipate earnings of $12.86 per share and a revenue of $6.11 billion, signifying shifts of +1727.85% and +18.87%, respectively, from the last year.

Investors should also pay attention to any latest changes in analyst estimates for Albemarle. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.

Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.

The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.94% downward. As of now, Albemarle holds a Zacks Rank of #3 (Hold).

With respect to valuation, Albemarle is currently being traded at a Forward P/E ratio of 9.09. This signifies a discount in comparison to the average Forward P/E of 14.87 for its industry.

The Chemical - Diversified industry is part of the Basic Materials sector. This industry, currently bearing a Zacks Industry Rank of 91, finds itself in the top 37% echelons of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.

, /PRNewswire/ -- The Board of Directors of Albemarle Corporation (NYSE: ALB) today announced that it declared a quarterly common stock dividend of $0.41 per share. The dividend, which has an annualized rate of $1.64, is payable Oct. 1, 2026, to shareholders of record at the close of business as of Sept. 11, 2026.

About Albemarle
Albemarle Corporation (NYSE: ALB) is a world leader in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allows us to deliver advanced solutions for our customers. Learn more about how the people of Albemarle are enabling a more resilient world at Albemarle.com.

Albemarle regularly posts information to Albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, U.S. Securities and Exchange Commission filings and other information regarding the company, its businesses and the markets it serves.

Forward-Looking Statements
This press release contains statements concerning our expectations, anticipations and beliefs regarding the future, including, without limitation, statements related to future dividends and results, which may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from the views expressed. Factors that could cause actual results to differ materially from the statements expressed or implied in any forward-looking statement include, without limitation: changes in economic and business conditions; potential expected market pricing of bromine, lithium and spodumene and other underlying assumptions and our 2026 outlook considerations; adverse changes in liquidity or financial or operating performance; changes in the demand for our products or the end-user markets in which our products are sold and the other factors detailed from time to time in the reports we file with the U.S. Securities and Exchange Commission, including those described under "Risk Factors" in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. These forward-looking statements speak only as of the date of this press release. We assume no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

Investor Relations Contact: +1 (980) 308-6194, [email protected]
Media Contact: Courtney St. Onge, +1 (980) 308-6310, [email protected] 

SOURCE Albemarle Corporation

Store

SubscribeSign In

My Subscriptions

Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD LiveCustomer Center

My Stock Lists

Email Preferences

Help & Support

Sign Out

Search stocks or keywords

Sections

My IBD

MARKET TREND

STOCK LISTS

STOCK RESEARCH

NEWSECONOMY

VIDEOS & PODCASTS

HOW TO INVESTEDUCATIONAL RESOURCESStoreMy Products

Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD Live

Recently Searched

Stock Market Week Ahead: Navigating Uncertainty

These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Google Holds Top Rating

ASML, Snowflake Lead Five Stocks Near Buy Points In Tough Market Rare earth stocks have been a ticket for riding a roller coaster for over a year, but the latest descent has been particularly brutal. Downward momentum gathered steam last Thursday, after the International Energy Agency's Global Critical Minerals Outlook 2026 edition highlighted a planned surge in mining capacity well beyond expectations of refining and magnet production. MP Materials (MP), USA…

Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

In the latest trading session, Albemarle (ALB - Free Report) closed at $119.46, marking a -4.23% move from the previous day. This move lagged the S&P 500's daily loss of 0.51%. At the same time, the Dow lost 0.2%, and the tech-heavy Nasdaq lost 1.47%.

Coming into today, shares of the specialty chemicals company had lost 25.11% in the past month. In that same time, the Basic Materials sector lost 8.52%, while the S&P 500 gained 0.53%.

Market participants will be closely following the financial results of Albemarle in its upcoming release. The company plans to announce its earnings on August 5, 2026. The company is expected to report EPS of $3.21, up 2818.18% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $1.52 billion, reflecting a 14.53% rise from the equivalent quarter last year.

In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $13.06 per share and a revenue of $6.13 billion, indicating changes of +1753.16% and +19.15%, respectively, from the former year.

It's also important for investors to be aware of any recent modifications to analyst estimates for Albemarle. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.

Our research shows that these estimate changes are directly correlated with near-term stock prices. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.

The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate has moved 5.44% higher. Right now, Albemarle possesses a Zacks Rank of #2 (Buy).

Looking at its valuation, Albemarle is holding a Forward P/E ratio of 9.55. For comparison, its industry has an average Forward P/E of 15.92, which means Albemarle is trading at a discount to the group.

The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 160, which puts it in the bottom 35% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.

Key Takeaways Albemarle is expanding lithium conversion capacity to capture rising demand.ALB is seeing higher Energy Storage volumes, supported by integrated conversion facilities.ALB's 2026 EPS estimate has trended higher over the past 60 days, with sharp year-over-year expected growth. Albemarle Corporation (ALB - Free Report) is strategically executing its projects aimed at boosting its global lithium conversion capacity. The market for lithium batteries and energy storage remains strong, offering significant opportunities for the company to develop innovative products and expand capacity.

ALB remains focused on investing in high-return projects to drive productivity. Healthy customer demand, capacity expansion and plant productivity improvements are supporting its volumes. ALB saw higher sales volumes (up 14% year over year) in its Energy Storage unit in the first quarter on the strength of its integrated conversion facilities.

The Salar yield improvement project in Chile has achieved a 50% operating rate, and the ramp-up continues to deliver encouraging outcomes. ALB has started the environmental permitting process for a commercial direct lithium extraction project at Salar de Atacama. The ramp-up at the Meishan lithium conversion facility in China is also progressing ahead of schedule.  The company’s volumes are expected to continue to be supported by these capacity expansion actions going forward.

Among its peers, Sociedad Quimica y Minera de Chile S.A. (SQM - Free Report) has a robust balance sheet and generates strong cash flows, which allow it to make investments in driving production capacity. SQM logged strong lithium sales volumes of 69,000 metric tons in the first quarter. The Nova Andino Litio business recorded roughly 19% higher volumes compared to the prior-year quarter, driven by capacity expansion actions. SQM is operating at full capacity at the Mt. Holland mine and concentrator in Australia and continues to ramp up the Kwinana refinery.

 Rio Tinto Group (RIO - Free Report) is making progress with its high-value lithium projects. The fully owned Rincon Lithium Project in Argentina remains on track with commissioning of the starter plant already being completed and ramp-up currently in progress, with full capacity expected by the end of 2026. The Fénix expansion project and Sal de Vida in Argentina, with a capital cost of $0.7 billion each, are mechanically complete with first production expected in second-half 2026.

The Nemaska Lithium project, in which Rio Tinto now holds a 53.9% stake with the Government of Québec retaining the balance, is a fully integrated spodumene-to-lithium hydroxide development project comprising the lithium hydroxide plant in Bécancour and the Whabouchi spodumene mine with a production capacity of 32,000 tons. RIO initially acquired a 50% interest in Nemaska Lithium through the buyout of Arcadium in March 2025.

ALB’s Price Performance, Valuation & EstimatesAlbemarle has gained 64.7% in the past year compared with the Zacks Chemical - Diversified industry’s decline of 2.8%.

Image Source: Zacks Investment Research

ALB is currently trading at a forward price-to-sales ratio of 2.32, above the industry. It carries a Value Score of C.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for ALB’s 2026 earnings implies a year-over-year rise of 1,753.2%. The EPS estimates for 2026 have been trending higher over the past 60 days.

Image Source: Zacks Investment Research

Key Takeaways Albemarle shares fell 25.5% in a month as weaker lithium prices pressured the stock.ALB is expanding lithium capacity, improving productivity and cutting costs to support growth.Albemarle expects lithium demand to witness a 10-20% CAGR from 2025 to 2030, led by storage. Albemarle Corporation’s (ALB - Free Report) shares have tumbled 25.5% in the past month, underperforming the Zacks Chemical - Diversified industry and the S&P 500’s declines of 6.7% and 0.1%, respectively. 

Falling lithium market prices are weighing on the ALB stock lately. Lithium prices have pulled back amid slowing demand for electric vehicles (EVs) in China, an inventory glut and prospects of increased supply from mine restarts and capacity additions. EV orders have slowed in China, the world’s biggest lithium consumer, while demand in energy storage systems remains healthy.

Meanwhile, China’s battery giant Contemporary Amperex Technology Co., Limited (CATL) has reportedly secured a safety production permit to resume production at its Jianxiawo lithium mine, with operations expected to resume soon. CATL suspended operations at the mine in August 2025, following the expiry of its mining permit. Mineral Resources has also announced the restart of operations at its fully-owned Bald Hill lithium mine in Western Australia. The mine was placed on care and maintenance in November 2024 amid weak lithium market conditions.

ALB’s One-month Price Performance Image Source: Zacks Investment Research

Reflecting the retreat in lithium prices, ALB stock broke below its 50-day simple moving average (SMA) on May 15, 2026. It also slipped below its 200-day SMA on June 23, 2026. Nonetheless, the 50-day SMA is reading higher than the 200-day SMA following a golden crossover on Sept. 3, 2025.

Albemarle Trades Below 50-Day SMA Image Source: Zacks Investment Research

Let’s take a look at ALB’s fundamentals to analyze the stock better.

Growing Lithium Demand and Productivity Aid ALBAlbemarle is well-placed to gain from long-term growth in the battery-grade lithium market. The market for lithium batteries and energy storage remains strong, offering significant opportunities for the company to develop innovative products and expand capacity. Lithium demand is expected to grow on the back of significant global EV penetration.

ALB expects lithium demand to witness a compound annual growth rate (CAGR) of 10-20% from 2025 to 2030. Stationary storage is expected to be a significant driver for lithium demand along with EVs. Albemarle expects demand to grow roughly 15-40% this year. Demand indicators stayed positive in the first quarter of 2026, with global Energy Storage Systems production rising 117% year over year.

The company is strategically executing its projects aimed at boosting its global lithium conversion capacity. It remains focused on investing in high-return projects to drive productivity. Healthy customer demand, capacity expansion and plant productivity improvements are supporting its volumes. ALB saw higher sales volumes (up 14% year over year) in its Energy Storage unit in the first quarter on the strength of its integrated conversion facilities.

The Salar yield improvement project in Chile has achieved a 50% operating rate, and the ramp-up continues to deliver encouraging outcomes. ALB has started the environmental permitting process for a commercial direct lithium extraction project at Salar de Atacama. The ramp-up at the Meishan lithium conversion facility in China is also progressing ahead of schedule.

Albemarle is taking aggressive cost-saving and productivity actions. The company delivered roughly $450 million in cost and productivity improvements for full-year 2025, having surpassed its initial target of $300-$400 million. It expects additional cost and productivity improvements of $100-$150 million in 2026, with $40 million already delivered this year. ALB is taking actions to maintain its competitive position, including the initiation of a comprehensive review of cost and operating structure, optimization of the conversion network and reduction of capital expenditure.

ALB’s Strong Financial Health Supports Capital AllocationAlbemarle remains committed to driving shareholder value by leveraging healthy cash flows and strong liquidity. Its operating cash flow was around $1.3 billion in 2025, up roughly 86% from the prior-year period. At the end of the first quarter, ALB had liquidity of around $2.7 billion, including cash and cash equivalents of around $1.1 billion. ALB generated an operating cash flow of $346 million and free cash flow of $248 million in the quarter.

The company paid down $1.3 billion of outstanding debt in March 2026, reducing annual interest expense by roughly $60 million. This followed the successful divestments of the controlling stake in Ketjen and its 50% interest in the Eurecat joint venture, which together generated $670 million in pre-tax proceeds.

The company remains focused on maintaining its dividend payout. It has raised its quarterly dividend for the 30th straight year. ALB offers a dividend yield of 1.3% at the current stock price. Its peers, Sociedad Quimica y Minera de Chile S.A. (SQM - Free Report) and Rio Tinto Group (RIO - Free Report) , have a dividend yield of 3.6% and 5.6%, respectively.

ALB’s Earnings Estimates NorthboundThe Zacks Consensus Estimate for 2026 for ALB has been revised upward over the past 60 days. The consensus estimate for second-quarter 2026 has been going up over the same time frame.

 The Zacks Consensus Estimate for 2026 earnings is currently pegged at $13.06, suggesting a year-over-year increase of 1,735.2%. Earnings are expected to increase roughly 2,818.2% in the second quarter.

Image Source: Zacks Investment Research

A Look at ALB’s ValuationALB is currently trading at a forward price-to-sales ratio of 2.34, above the industry’s 0.88. It is trading at a modest discount to Sociedad Quimica and at a premium to Rio Tinto. Both Albemarle and Sociedad Quimica currently have a Value Score of C, while Rio Tinto has a Value Score of B.

ALB’s P/S F12M Vs. Industry, SQM and RIO Image Source: Zacks Investment Research

How Should Investors Play ALB Stock?Albemarle is gaining from increased lithium volumes, supported by project ramp-ups, ongoing efforts to expand its global lithium conversion capacity and productivity improvement initiatives. The company remains well-positioned to benefit from the long-term expansion of the battery-grade lithium market. Robust growth prospects and rising earnings estimates are some other positives. Although ALB trades at a premium valuation, its strong fundamentals and earnings growth potential justify the higher multiple. Notwithstanding the recent pullback in lithium prices, we advise investors to bet on this Zacks Rank #2 (Buy) stock now, as it has solid earnings growth prospects.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It’s not hard to see why investing in rare-earth metals is a long-term investment theme. Rare-earth metals are 17 metallic elements with unusual magnetic, optical, and conductive properties that make them indispensable to modern technology, including:

Defense and national security

Artificial intelligence, semiconductors, and data centers

Electrification and clean energy

The rare-earth story is frequently positioned as one of scarcity, but that isn't the case. Many countries have abundant rare-earth deposits, including the United States, Australia, Canada, Brazil, and India.

Get REMX alerts:

China's dominance in rare-earths stems from decades of developing its midstream processing industry, rather than just controlling the largest deposits. Beginning in the 1980s, China invested heavily in refining, separation technology, chemical engineering capacity, and magnet manufacturing—areas that other countries avoided because of cost, environmental complexity, and long development timelines.

Rare-earth refining is chemically intensive and produces radioactive byproducts, and China’s willingness to subsidize the industry and manage the environmental burden allowed it to scale rapidly while competitors fell behind. This is where today’s investment opportunities exist.

Why Rare-Earth Refining Is the Real Investment OpportunityThe bottleneck in rare-earth is in the refining process. This was a conscious choice that was made by China (to invest in refining) and many other countries, including the United States, which chose not to invest in refining.

The Trump administration is accelerating domestic rare‑earth development through targeted industrial policy, including federal funding, strategic partnerships, and streamlined permitting for critical‑mineral projects. Rather than broad deregulation, the focus has been on removing specific bottlenecks that historically made U.S. refining uneconomic—such as long environmental review timelines and limited federal support for midstream processing.

These policy shifts are designed to help companies begin refining rare-earth elements inside the United States for the first time in decades. As a result, several U.S. companies are now receiving federal support to build refining, separation, and magnet‑manufacturing capacity—marking the first major rebuild of the domestic rare‑earth supply chain in more than 30 years.

MP Materials NYSE: MP: The Pentagon became the company’s largest shareholder after buying $400 million in preferred stock in July 2025. The investment supports the company’s expansion of rare-earth processing and the construction of a second magnet manufacturing plant.

USA Rare Earth NASDAQ: USAR: The Trump administration announced a partnership in early 2026 that gives the company access to $1.6 billion in funding. The deal also issued 16.1 million shares to the Department of War, which could increase the government’s stake to between 12% and 25%, depending on warrant exercise.

Vulcan Elements & ReElement Technologies: The Department of War issued these rare-earth startups a $620 million loan and $50 million in federal incentives. The investment is to help the companies scale their magnet and ore processing capacity.

This is where some investors may believe the opportunity carries too much risk. After all, there are no guarantees in this sector, and the real payoff is likely years away. However, for patient investors with a long-term outlook, that’s an ideal argument for investing in an exchange-traded fund (ETF) that includes dozens of holdings in the sector. This provides exposure to the entire supply chain without overreliance on one or two companies.

REMX: A Diversified ETF for Rare-Earth InvestingVanEck Rare Earth and Strategic Metals ETF Today

REMX

VanEck Rare Earth and Strategic Metals ETF

$79.76 -0.27 (-0.34%)

As of 07/10/2026 04:10 PM Eastern

52-Week Range$46.30▼

$111.55Dividend Yield1.63%

Assets Under Management$2.40 billion

The VanEck Rare Earth and Strategic Metals ETF NYSEARCA: REMX tracks an index of global companies that mine, refine, or recycle rare-earth and strategic metals.

The fund is an ideal option for investors looking for a direct proxy for the current export-control backdrop,

REMX is a weighted average market cap fund with 38 holdings. Albemarle NYSE: ALB holds the most weight in the fund at around 7.2%. The fund has $2.4 billion of assets under management (AUM) with a net expense ratio of 0.58%.

REMX is up over 91% in the last 12 months. But a sharp sell-off that started in May has pushed the stock price into the middle of its 52-week range, which may create a solid entry point for investors.

EART ETF Targets the Companies Powering Future TechnologiesGlobal X Rare Earth & Critical Materials ETF Today

EART

Global X Rare Earth & Critical Materials ETF

$27.43 +0.13 (+0.48%)

As of 07/10/2026 03:47 PM Eastern

52-Week Range$17.42▼

$36.92Dividend Yield0.66%

Assets Under Management$39.03 million

The Global X Rare Earth & Critical Materials ETF NASDAQ: EART is a more targeted play on the rare-earth theme.

The fund targets companies that produce rare-earth components and other raw or composite materials that are essential to expanding the development of critical technologies such as electric vehicles (EVs), energy storage, robotics, and radar systems.

The fund has over 50 holdings that are weighted according to their Free Float Market Capitalization. The fund currently has around $40 million of AUM with a net expense ratio of 0.59%.

EART is up over 60% in the last 12 months. Like the REMX, the fund has been in a downtrend since mid-May, giving investors a similar opportunistic setup.

SETM ETF Provides Diversified Critical Materials ExposureSprott Critical Materials ETF Today

SETM

Sprott Critical Materials ETF

$30.41 +0.14 (+0.46%)

As of 07/10/2026 04:00 PM Eastern

52-Week Range$18.21▼

$40.55Assets Under Management$563.27 million

In contrast to the EART, which takes a narrower focus on the rare-earth sector, the Sprott Critical Materials ETF NASDAQ: SETM takes a broader view and includes a focus on several critical metals that are essential to the modern industrial economy.

For example, in percentage terms, uranium companies have the most exposure in the fund.

With its focus on a wider range of metals, the fund has at any given time between 125 and 170 holdings, which provides significant diversification. The fund has close to $560 million of AUM and a net expense ratio of 0.65%.

SETM is up 74% in the last 12 months. But like the broader sector, the fund is down over 14% in the last three months.

Should You Invest $1,000 in VanEck Rare Earth and Strategic Metals ETF Right Now?Before you consider VanEck Rare Earth and Strategic Metals ETF, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and VanEck Rare Earth and Strategic Metals ETF wasn't on the list.

While VanEck Rare Earth and Strategic Metals ETF currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 8, 2026) - Investorideas.com, a leader in mining investing news and home of the Exploring Mining Podcast issues a snapshot of mining stocks betting on the Carolina's new wave of exploration and discovery, featuring Metalsource Mining Inc. (CSE: MSM) (OTCQB: MSMMF) (FSE: E9Z).

Mining in the Carolinas - Betting on History for a Second Wave of Discovery

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6292/304357_ed26ef5af443ba37_001full.jpg

While the Carolinas are historically renowned for their gold mining heritage, most notably as the site of America's first gold discovery at the Reed Mine in 1799, the region's Carolina Slate Belt also hosts significant polymetallic systems containing silver along with base metals such as lead and zinc. These deposits are actively being explored and advanced by junior companies in a top-tier US jurisdiction featuring private land ownership and favorable permitting conditions.

Recent advances in geophysical surveying techniques, combined with strong precious metals prices have ignited renewed interest in the Carolina Slate Belt, inciting a modern-day "second gold rush." This resurgence has drawn a fresh wave of publicly traded junior mining companies to the region, eager to apply contemporary exploration methods to its underexplored polymetallic and precious metal systems.

An example of this strategy in action is junior miner Metalsource Mining Inc. (CSE: MSM) (OTCQB: MSMMF) (FSE: E9Z), advancing the Silver Hill and Byrd-Pilot projects in North Carolina.

Silver Hill is recognized as America's first significant silver discovery and the location of the nation's first commercial silver production in 1838. The project features steeply dipping polymetallic lenses with silver-gold-lead-zinc mineralization that remain open in multiple directions, supported by extensive historical drill data, underground mapping and recent surface sampling.

The company has recently expanded its land position through strategic acquisitions to approximately 1,300 acres and is conducting systematic drilling and geophysical programs (including induced polarization and magnetotelluric surveys) to define and expand high-grade zones.

Highlights

Land position expanded to approximately 1,300 acres through option agreements covering three additional properties.Newly acquired ground is interpreted to be along strike and down dip of known mineralization and part of the evolving Silver Hill geological model.Expansion supports the Company's objective of evaluating the broader district scale potential beyond the historic mine footprint.Exploration continues across Silver Hill with multiple assays pending while management advances plans to increase drilling capacity.Joe Cullen, CEO of Metalsource Mining, commented:
"This is a strategic acquisition we've been working toward for some time. As drilling, geophysics and geological interpretation have continued to improve our understanding of the Silver Hill system, it became increasingly important to secure these highly prospective properties while the opportunity was available. We're grateful to the families who have owned this land for generations and appreciate the trust they've placed in our team. Every successful drill hole has strengthened our confidence in the broader district and helped define where we believe the next phase of exploration should be focused. These newly acquired properties provide access to compelling exploration targets that we look forward to advancing in the near term as we continue expanding the known mineralized footprint at Silver Hill.

As we move closer to increasing drilling capacity, our vision is clear: one program focused on systematically expanding the Silver Hill proper, while additional drilling evaluates high priority regional targets generated through our geological work and recent IP surveys. We believe we're still in the early stages of understanding the scale of this district, and we're excited by the potential for both resource expansion and new discoveries."

What's Next

Multiple assays pending from the current drill campaign, with results expected to continue advancing the Company's understanding of the Silver Hill system.Increasing drilling capacity as management advances plans to secure an additional drill rig to accelerate testing of both known mineralization and newly identified exploration targets.Testing the broader district through continued integration of drilling, IP geophysics and geological interpretation to prioritize additional targets beyond the historic mine footprint.Continuing strategic growth through evaluation of additional land opportunities that complement the Company's evolving district scale exploration strategy.Why This Matters to Investors
The expansion of the Silver Hill land package reflects management's growing confidence in the broader exploration potential of the district. As drilling, geological interpretation and property scale geophysical surveys continue to refine the Company's understanding of the system, Metalsource is strategically securing prospective ground that may host mineralization and additional high priority exploration targets.

The newly acquired properties are expected to play an important role in the next phase of exploration. While the current drill program continues to systematically expand the known Silver Hill deposit, these acquisitions position the Company to evaluate a growing pipeline of prospective targets across the broader district as additional drilling capacity comes online.

With multiple drill holes pending, plans to accelerate exploration and an expanding portfolio of high priority targets, Metalsource believes it is transitioning from exploring a historic mine to systematically unlocking the broader district scale potential of one of America's most historically significant polymetallic mining camps.

Full news:
https://www.metalsourcemining.com/20260702-metalsource-mining-expands-silver-hill-district-through-strategic-land-acquisition-as-exploration-footprint-continues-to-grow

On June 30th, Metalsource Mining announced additional assay results from its ongoing drill program at Silver Hill, where systematic step out drilling continues to improve management's understanding of the continuity and orientation of a growing high grade polymetallic system.

Hole SH26-19 returned 6.28 metres grading 1,156 g/t silver equivalent ("AgEq"), including 3.6 metres grading 1,789 g/t AgEq. Positioned at the southern edge of recent drilling, the intersection contains elevated gold and silver values coincident with high grade massive sphalerite, providing additional confidence in the Company's evolving geological model and continued vectoring toward new mineralization.

The Silver Hill polymetallic system remains open along strike, down plunge and at depth. With multiple drill hole results currently pending, Metalsource believes the current exploration program is still in the early stages of defining the scale and continuity of the system.

Full news:
https://www.metalsourcemining.com/20260630-metalsource-mining-continues-to-define-high-grade-polymetallic-core-at-silver-hill-with-33-metre-down-plunge-step-out

The Byrd-Pilot Project in Randolph County adds further gold-silver potential within the same prospective terrane. Together, these assets highlight the untapped polymetallic opportunity in a district long overshadowed by its gold history but now benefiting from modern exploration techniques.

The Byrd-Pilot project totals 1,000 acres and is located in Randolph County, North Carolina. With intercepts demonstrating consistent gold mineralization and a 450-metre trend of anomalous trench results, Byrd-Pilot represents a district-scale system that remains largely untested at depth.

Video overview of mining projects:

Cannot view this video? Visit:
https://www.youtube.com/watch?v=P3cUTKxOmZ8

Another active player in the Carolina's is OceanaGold Corporation (TSX: OGC) (NYSE: OGC) operating the Haile Gold Mine in South Carolina, a site boasting millions of ounces in reserves. The Haile Gold Mine is one of the largest active gold mines in the eastern United States.

In May, OceanaGold announced high-grade results from its ongoing exploration and resource conversion drilling program at the Haile Gold Mine in the United States.

Drilling Highlights (core length):

Horseshoe Underground (conversion and extension drilling):

15.5 m @ 30.64 g/​t Au (UGD0121)
30.5 m @ 13.86 g/​t Au (UGD0113)
22.5 m @ 13.42 g/​t Au (UGD0122)
18.4 m @ 9.62 g/​t Au (UGD0119)
21.9 m @ 6.48 g/​t Au including 3.7 m @ 23.55 g/​t Au (UGD0120)
26.3 m @ 3.41 g/​t Au and 44.3 m @ 3.72 g/​t Au (UGD0107)

Ledbetter Underground (conversion drilling):

27.9 m @ 8.60 g/​t Au (DDH1313)
27.9 m @ 4.16 g/​t Au (DDH1319)
18.4 m @ 3.68 g/​t Au (DDH1317)
13.0 m @ 2.25 g/​t Au and 17.1 m @ 8.20 g/​t Au (DDH1283)
2.6 m @ 9.63 g/​t Au and 3.3 m @ 40.45 g/​t Au (DDH1315)

Clydesdale (initial drilling):

14.5 m @ 15.81 g/​t Au including 4.5 m @ 41.6 g/​t Au (DDH1305)

Gerard Bond, President and CEO of OceanaGold, said,​"Our ongoing exploration success at Haile continues to demonstrate our ability to add tremendous value through the drill bit. At Horseshoe, recent drilling points to reserve growth potential near existing infrastructure, with mineralization still open in multiple directions. Results from Ledbetter are strengthening confidence in down-plunge resource conversion, and a new significant high-grade intercept at Clydesdale confirms its potential as an emerging target area. As development of the Palomino decline progresses, we look forward to advancing these opportunities with further drilling from underground in the near term."

Full news - https://oceanagold.com/news/oceanagold-announces-additional-high-grade-drill-results-at-haile

Another junior, Carolina Rush Corporation (TSXV: RUSH) (OTCQB: PUCCF) is advancing the historical Brewer Gold-Copper Project in Chesterfield County, South Carolina, which is situated just 17 km from OceanaGold's Haile Mine.

North Carolina is also making headlines with its lithium deposits. According to USGS.gov, in June - "The southern Appalachian region of the eastern United States contains an estimated 1.43 million metric tons of undiscovered, economically recoverable lithium oxide, enough to replace 201 years of U.S. imports at last year's level, according to new research by the U.S. Geological Survey."

"Before the boom in lithium demand, North Carolina's Kings Mountain and Hallman-Beam mines produced lithium from pegmatites but closed in the 1990s when production shifted to lower-cost sources such as lithium from dried lakebeds in South America and pegmatites in Australia. At the time, lithium was principally used for ceramics, glass and lubricating grease."

Albemarle Corp., (NYSE: ALB) headquartered in Charlotte, NC, operates in the historic Kings Mountain lithium region and is one of the world's largest lithium producers.

On March 12, 2026 they reported: "Albemarle has reached a project milestone at our Kings Mountain, North Carolina, proposed mine project with the successful completion of dewatering the site's open pit."

Continued:

As one of North America's largest hard-rock lithium deposits, the Kings Mountain Mine has the potential to be a cornerstone of a U.S.-based lithium supply chain. The proposed mine has the potential to produce and process nearly 3.1 million tons of lithium-bearing spodumene ore annually.

When mining operations ceased in the early 1990s, the pit gradually filled with rainwater over several decades and eventually accumulated more than a billion gallons. To further advance prefeasibility studies and evaluate the potential restart of mining operations, that water needed to be safely removed.

The completion of dewatering marks a significant step forward for Albemarle's long-term plans at the Kings Mountain site. The company can continue its technical studies and planning efforts as it evaluates the potential redevelopment of one of North America's most important lithium resources.

Leveraging a storied mining past, the Carolinas are now experiencing a fresh wave of discovery and development as forward-looking companies invest in the region's future

Metalsource Mining Inc. (CSE: MSM) (OTCQB: MSMMF) (FSE: E9Z) is a paid featured mining stock.at Investorideas.com

https://www.investorideas.com/CO/MSM/

Research more mining stocks at Investorideas.com free stock directory
https://www.investorideas.com/Gold_Stocks/Stocks_List.asp

Sign up for free trading and stock news alerts at Investorideas.com
https://www.investorideas.com/Resources/Newsletter.asp

About Investorideas.com - where you find the best investing ideas
Investorideas.com is a trusted platform for retail investors, serving as a hub for innovative investing ideas for over 25 years.

Disclaimer/Disclosure: Metalsource Mining Inc. is a paid featured mining stock on Investor ideas. More payment details and disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. More disclosure: Contact management and IR of each company directly regarding specific questions.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Follow us on X @investorideas @stocknewsbites
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas

Contact Investorideas.com
800 665 0411

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304357

Source: Econ Corp Services DBA Investorideas.com

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

In the latest trading session, Albemarle (ALB - Free Report) closed at $133.80, marking a -1.3% move from the previous day. The stock's change was less than the S&P 500's daily gain of 0.72%. On the other hand, the Dow registered a gain of 0.3%, and the technology-centric Nasdaq increased by 1.12%.

Prior to today's trading, shares of the specialty chemicals company had lost 12.79% lagged the Basic Materials sector's loss of 5.59% and the S&P 500's loss of 0.9%.

Investors will be eagerly watching for the performance of Albemarle in its upcoming earnings disclosure. On that day, Albemarle is projected to report earnings of $3.21 per share, which would represent year-over-year growth of 2818.18%. Our most recent consensus estimate is calling for quarterly revenue of $1.53 billion, up 15.08% from the year-ago period.

In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $12.98 per share and a revenue of $6.11 billion, indicating changes of +1743.04% and +18.78%, respectively, from the former year.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Albemarle. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.

Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 4.8% higher. Albemarle is currently a Zacks Rank #1 (Strong Buy).

In the context of valuation, Albemarle is at present trading with a Forward P/E ratio of 10.44. This indicates a discount in contrast to its industry's Forward P/E of 15.82.

The Chemical - Diversified industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 170, putting it in the bottom 31% of all 250+ industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.

Albemarle (ALB - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Shares of this specialty chemicals company have returned -21.4% over the past month versus the Zacks S&P 500 composite's -1.8% change. The Zacks Chemical - Diversified industry, to which Albemarle belongs, has lost 8.3% over this period. Now the key question is: Where could the stock be headed in the near term?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

Albemarle is expected to post earnings of $3.21 per share for the current quarter, representing a year-over-year change of +2818.2%. Over the last 30 days, the Zacks Consensus Estimate has changed +4.3%.

For the current fiscal year, the consensus earnings estimate of $12.98 points to a change of +1743% from the prior year. Over the last 30 days, this estimate has changed +4.8%.

For the next fiscal year, the consensus earnings estimate of $13.38 indicates a change of +3.1% from what Albemarle is expected to report a year ago. Over the past month, the estimate has changed +5.9%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Albemarle is rated Zacks Rank #1 (Strong Buy).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of Albemarle, the consensus sales estimate of $1.53 billion for the current quarter points to a year-over-year change of +15.1%. The $6.11 billion and $6.49 billion estimates for the current and next fiscal years indicate changes of +18.8% and +6.3%, respectively.

Last Reported Results and Surprise HistoryAlbemarle reported revenues of $1.43 billion in the last reported quarter, representing a year-over-year change of +32.7%. EPS of $2.95 for the same period compares with -$0.18 a year ago.

Compared to the Zacks Consensus Estimate of $1.33 billion, the reported revenues represent a surprise of +7.82%. The EPS surprise was +137.9%.

Over the last four quarters, Albemarle surpassed consensus EPS estimates three times. The company topped consensus revenue estimates each time over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Albemarle is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Albemarle. However, its Zacks Rank #1 does suggest that it may outperform the broader market in the near term.

Albemarle (ALB - Free Report) has been beaten down lately with too much selling pressure. While the stock has lost 24.2% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.

We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.

RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.

Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.

So, by this measure, if a stock has gotten too far below its fair value just because of unwarranted selling pressure, investors may start looking for entry opportunities in the stock for benefiting from the inevitable rebound.

However, like every investing tool, RSI has its limitations, and should not be used alone for making an investment decision.

Why ALB Could Bounce Back Before LongThe RSI reading of 27.16 for ALB is an indication that the heavy selling could be in the process of exhausting itself, so the stock could bounce back in a quest for reaching the old equilibrium of supply and demand.

This technical indicator is not the only factor that calls for a potential rebound for the stock. There is a fundamental indicator as well. A strong agreement among sell-side analysts covering ALB in raising earnings estimates for the current year has led to an increase in the consensus EPS estimate by 4.8% over the last 30 days. And an upward trend in earnings estimate revisions usually translates into price appreciation in the near term.

Moreover, ALB currently has a Zacks Rank #1 (Strong Buy), which means it is in the top 5% of more than 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. This is a more conclusive indication of the stock's potential turnaround in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

56.17K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in ALB over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

The information contained herein is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Before buying or selling any stock, you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

HomeStock IdeasLong IdeasBasic Materials

SummaryAlbemarle Corporation remains tightly correlated to lithium carbonate price volatility, with its share price mirroring lithium’s movements.Recent rumors of CATL’s Jianxiawo mine reopening have pressured lithium prices, yet confirmation is lacking and supply-demand conditions remain relatively tight.ALB’s stock has rebounded but remains 53% below its all-time high, reflecting persistent uncertainty in lithium markets.Forward returns for ALB will hinge on lithium price direction, as new battery capacity and supply developments unfold in the coming quarters. Daniel Grinspun /iStock via Getty Images

Checking in on a US lithium major Albemarle Corporation (ALB) is a name that I've covered frequently on Seeking Alpha, with my last piece published in September of 2025 was when

10.33K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ALB.PR.A either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Disclaimer: The information in this article is intended for general informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. The views expressed are solely those of the author, based on independent research, analysis, and professional experience. Although the author is a CERTIFIED FINANCIAL PLANNER™ (CFP®) and owner of Ashcroft Green Advisors, a fee-only registered investment advisory firm, the content may not be suitable for your individual financial situation, objectives, or risk tolerance. Readers should consult with a qualified financial professional before making any decisions based on this material. The author and/or clients of Ashcroft Green Advisors may hold positions in securities discussed in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

In the latest close session, Albemarle (ALB - Free Report) was down 2.28% at $156.69. The stock's performance was behind the S&P 500's daily loss of 0.37%. On the other hand, the Dow registered a gain of 0.29%, and the technology-centric Nasdaq decreased by 1.33%.

Coming into today, shares of the specialty chemicals company had lost 6.55% in the past month. In that same time, the Basic Materials sector gained 3.31%, while the S&P 500 gained 2.02%.

Investors will be eagerly watching for the performance of Albemarle in its upcoming earnings disclosure. The company is predicted to post an EPS of $3.08, indicating a 2700% growth compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $1.48 billion, up 11.36% from the year-ago period.

For the full year, the Zacks Consensus Estimates are projecting earnings of $12.39 per share and revenue of $5.99 billion, which would represent changes of +1668.35% and +16.45%, respectively, from the prior year.

Investors should also pay attention to any latest changes in analyst estimates for Albemarle. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.

Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 7.74% higher. Albemarle is holding a Zacks Rank of #1 (Strong Buy) right now.

With respect to valuation, Albemarle is currently being traded at a Forward P/E ratio of 12.94. Its industry sports an average Forward P/E of 15.51, so one might conclude that Albemarle is trading at a discount comparatively.

It's also important to note that ALB currently trades at a PEG ratio of 0.81. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Chemical - Diversified was holding an average PEG ratio of 1.15 at yesterday's closing price.

The Chemical - Diversified industry is part of the Basic Materials sector. At present, this industry carries a Zacks Industry Rank of 73, placing it within the top 30% of over 250 industries.

The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.

Key Takeaways Albemarle paid down $1.3B of debt, cutting annual interest expense by about $60M.Albemarle reduced long-term debt to $1.81B and ended Q1 with 1x net debt-to-EBITDA.ALB has roughly $2.7B in liquidity, with no major debt maturities due until late 2028. Albemarle Corporation (ALB - Free Report) remains committed to paying down debt and strengthening its balance sheet. The company paid down $1.3 billion of outstanding debt in March 2026, reducing annual interest expense by roughly $60 million. This followed the successful divestments of the controlling stake in Ketjen and its 50% interest in the Eurecat joint venture, which together generated $670 million in pre-tax proceeds.

ALB’s long-term debt was $1.81 billion at the quarter-end, down from $3.12 billion at the end of 2025. The company ended the first quarter with a net debt-to-EBITDA leverage ratio of 1x. It has no major maturities due until late 2028.

At the end of the quarter, ALB had liquidity of around $2.7 billion, including cash and cash equivalents of around $1.1 billion. Its deleveraging efforts are expected to continue to result in improved balance sheet and financial flexibility while reducing interest expenses.

Among its peers, Sociedad Quimica y Minera de Chile S.A. (SQM - Free Report) exited the first quarter with long-term debt of around $4.79 billion, up from $4.22 billion as of Dec. 31, 2025. SQM had strong liquidity, with cash and cash equivalents of around $2.8 billion at the end of the quarter. Sociedad Quimica, in early December 2025, issued a hybrid bond for roughly $430 million to refinance debt and fund its investment plan.

ICL Group Ltd. (ICL - Free Report) ended the first quarter with outstanding net debt of roughly $2.57 billion, up $309 million from the end of 2025. Including unutilized revolving credit facility and securitization, ICL Group had cash resources of $1.49 billion at the end of the quarter. ICL has priced a private offering of $800 million senior notes due 2036 and plans to use part of the net proceeds from the offering for the repayment, in part or in full, of outstanding borrowings under its revolving credit facility maturing in April 2030, and to repay other debt.

ALB’s Price Performance, Valuation & EstimatesAlbemarle has gained 25.4% in the past six months compared with the Zacks Chemical - Diversified industry’s rise of 25.9%.

Image Source: Zacks Investment Research

ALB is currently trading at a forward price-to-sales ratio of 3.24, above the industry. It carries a Value Score of D.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for ALB’s 2026 earnings implies a year-over-year rise of 1,668.4%. The EPS estimates for 2026 have been trending higher over the past 60 days.

Image Source: Zacks Investment Research

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Albemarle (ALB - Free Report) .

Albemarle currently has an average brokerage recommendation (ABR) of 1.88, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 25 brokerage firms. An ABR of 1.88 approximates between Strong Buy and Buy.

Of the 25 recommendations that derive the current ABR, 13 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 52% and 8% of all recommendations.

Brokerage Recommendation Trends for ALB

Check price target & stock forecast for Albemarle here>>>

The ABR suggests buying Albemarle, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.

Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.

In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.

With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.

Zacks Rank Should Not Be Confused With ABRAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.

The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.

On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.

There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.

Is ALB Worth Investing In?In terms of earnings estimate revisions for Albemarle, the Zacks Consensus Estimate for the current year has increased 7.7% over the past month to $12.39.

Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #1 (Strong Buy) for Albemarle. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, the Buy-equivalent ABR for Albemarle may serve as a useful guide for investors.

Albemarle's share price declined by about 20% recently, making this a good initial entry point. Part of the decline can arguably be attributed to the shutdown of its Australia plant, which resulted in a sizable loss. Long-term fundamentals for lithium look good on the positive correlation between oil & lithium prices.

Key Takeaways Albemarle and Rio Tinto are well-positioned to benefit from rising lithium demand and prices.ALB focuses on capacity expansion, cost cuts and strong cash flow to support growth.RIO advances major lithium projects, boosts output and leverages a strong balance sheet. Albemarle Corporation (ALB - Free Report) and Rio Tinto Group (RIO - Free Report) are prominent players in the lithium space. Both companies are well-positioned to gain from higher lithium prices, fueled by robust demand from electric vehicles (EVs) and energy storage systems, as well as supply disruptions linked in part to production cuts in China. Lithium prices have rebounded from last year’s lows amid tightening supply conditions and healthy demand in China and across global markets.

Let’s dive deep and closely compare the fundamentals of these two lithium producers to determine which one is a better investment option now amid improving lithium market conditions.

The Case for ALBAlbemarle is well-placed to gain from long-term growth in the battery-grade lithium market. The market for lithium batteries and energy storage remains strong, especially for EVs, offering significant opportunities for the company to develop innovative products and expand capacity. Lithium demand is expected to grow on the back of significant global EV penetration. ALB expects lithium demand to witness a compound annual growth rate (CAGR) of 10-20% from 2025 to 2030. Stationary storage is expected to be a significant driver for lithium demand along with EVs. Albemarle expects demand to grow roughly 15-40% this year. Demand indicators stayed positive in the first quarter of 2026, with global Energy Storage Systems production rising 117% year over year.

The company is strategically executing its projects aimed at boosting its global lithium conversion capacity. It remains focused on investing in high-return projects to drive productivity. Healthy customer demand, capacity expansion and plant productivity improvements are supporting its volumes. ALB saw higher sales volumes (up 14% year over year) in its Energy Storage unit in the first quarter on the strength of its integrated conversion facilities. The Salar yield improvement project in Chile has achieved a 50% operating rate, and the ramp-up continues to deliver encouraging outcomes.

ALB has started the environmental permitting process for a commercial direct lithium extraction project at Salar de Atacama. The ramp-up at the Meishan lithium conversion facility in China is also progressing ahead of schedule. The CGP3 expansion at the Greenbushes spodumene mine in Australia has been expedited, expected to reach full production later this year, and add to capacity.

Albemarle is taking aggressive cost-saving and productivity actions as well. The company delivered roughly $450 million in cost and productivity improvements for full-year 2025, having surpassed its initial target of $300-$400 million. It expects additional cost and productivity improvements of $100-$150 million in 2026, with $40 million already delivered this year. ALB is taking actions to maintain its competitive position, including the initiation of a comprehensive review of cost and operating structure, optimization of the conversion network and reduction of capital expenditure. Its capital expenditures of $590 million for 2025 decreased 65% year over year.

  Albemarle remains committed to driving shareholder value by leveraging healthy cash flows and strong liquidity. Its operating cash flow was around $1.3 billion in 2025, up roughly 86% from the prior-year period. At the end of the first quarter, ALB had liquidity of around $2.7 billion, including cash and cash equivalents of around $1.1 billion. ALB generated an operating cash flow of $346 million and free cash flow of $248 million in the quarter.

The company paid down $1.3 billion of outstanding debt in March 2026, reducing annual interest expense by roughly $60 million. This followed the successful divestments of the controlling stake in Ketjen and its 50% interest in the Eurecat joint venture, which together generated $670 million in pre-tax proceeds.

The company remains focused on maintaining its dividend payout. It has raised its quarterly dividend for the 30th straight year. ALB offers a dividend yield of 0.9% at the current stock price.

The Case for RIORio Tinto holds one of the world’s largest lithium portfolios and a robust pipeline of development projects, positioning it well to benefit from the growing demand for lithium.  RIO produces lithium using several established methods, including direct lithium extraction (“DLE”) from brines, traditional pond-based brine extraction and hard-rock mining. The company also manufactures a broad suite of lithium products, including lithium chloride, lithium carbonate, lithium hydroxide, and spodumene concentrate.

RIO is expanding its lithium extraction capabilities through a new partnership with ILiAD Technologies, a leader in DLE technology. The collaboration supports the company’s efforts to enhance operational efficiency while improving sustainability and cost effectiveness. ILiAD’s technology allows the extraction of high-purity lithium chloride from a wide range of lithium-rich brine resources and complements RIO’s existing DLE operations at Fénix and Rincon.

RIO is making progress with its high-value lithium projects. The fully owned Rincon Lithium Project in Argentina remains on track with commissioning of the starter plant already being completed and ramp-up currently in progress, with full capacity expected by the end of 2026. RIO is investing $2.5 billion to expand Rincon, which has a capacity of 60,000 tons of battery-grade lithium carbonate annually with a 40-year mine life. First production from the project is expected in 2028, followed by a three-year ramp-up to full capacity. Rio Tinto has secured a $1.175 billion financing package from international lenders to support the development of the Rincon project.

The Fénix expansion project and Sal de Vida in Argentina, with a capital cost of $0.7 billion each, are mechanically complete with first production expected in second-half 2026. The Nemaska Lithium project, in which Rio Tinto now holds a 53.9% stake with the Government of Québec retaining the balance, is a fully integrated spodumene-to-lithium hydroxide development project comprising the lithium hydroxide plant in Bécancour and the Whabouchi spodumene mine with a production capacity of 32,000 tons. RIO initially acquired a 50% interest in Nemaska Lithium through the buyout of Arcadium in March 2025.

At Bécancour, engineering has been completed with construction at more than 70%. RIO has decided to slow the pace of construction of the project during 2026, but remains fully committed to advancing the project. It expects construction to ramp up following optimization works and does not envision major changes to the project’s overall timeline. Commissioning of the Bécancour plant was planned to start this year, with first production in 2028.

RIO has a robust balance sheet and generates strong cash flows, which allow it to make investments in projects while driving shareholder returns. The company ended 2025 with cash and cash equivalents and other short-term highly liquid investments of $9.2 billion. RIO generated an operating cash flow of $16.8 billion in 2025, up 8% year over year. Rio Tinto has a policy of returning 40-60% of its underlying earnings, with a 10-year track record of dividend payout at the top end of the range. It offers a dividend yield of 4.8% at the current stock price.

ALB & RIO: Price Performance, Valuation & Other ComparisonsThe ALB stock has surged 200.9% over the past year, while RIO has rallied 78.4%.

Image Source: Zacks Investment Research

ALB is currently trading at a forward price-to-sales ratio of 3.32. RIO is currently trading at a forward price-to-sales ratio of 2.18, below ALB.

Image Source: Zacks Investment Research

ALB’s long-term debt-to-capitalization is around 15.2%, lower than RIO’s 24.6%.  

Image Source: Zacks Investment Research

How the Zacks Consensus Estimate Compares for ALB & RIOThe Zacks Consensus Estimate for ALB’s 2026 sales implies year-over-year growth of 16.7%. The same for EPS suggests a 1,675.9% year-over-year rise. The EPS estimates for 2026 have been trending higher over the past 60 days.

Image Source: Zacks Investment Research

The consensus estimate for RIO’s 2026 sales and EPS implies a year-over-year rise of 13% and 28%, respectively. The EPS estimates for 2026 have been trending northward over the past 60 days.

Image Source: Zacks Investment Research

ALB or RIO: Which Stock Holds the Edge?ALB and RIO stand to benefit from rising lithium prices driven by EV and energy storage demand. Albemarle is benefiting from higher lithium volumes on project ramp-ups and actions to boost global lithium conversion capacity and productivity. RIO is advancing major lithium projects to boost output and leveraging a strong balance sheet. ALB's higher earnings growth projections suggest that it may offer better investment prospects in the current market environment. ALB’s lower leverage also suggests lower financial risks. Investors seeking exposure to the lithium space might consider Albemarle as the more favorable option at this time.

ALB currently carries a Zacks Rank #1 (Strong Buy), while RIO has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank stocks here.

Key Takeaways ALB generated $248M in Q1 free cash flow and ended the quarter with $2.7B liquidity.Albemarle's 2026 free cash flow is expected to be supported by higher lithium prices and productivity.ALB targets 2026 operating cash flow conversion within its 60-70% long-term range at $20 per kg lithium price. Albemarle Corporation (ALB - Free Report) remains committed to driving shareholder value by leveraging solid liquidity and healthy cash flows. At the end of the first quarter of 2026, ALB had liquidity of around $2.7 billion, including cash and cash equivalents of around $1.1 billion. It generated an operating cash flow of $346 million and free cash flow of $248 million in the quarter.

ALB generated free cash flow of $692 million for full-year 2025, driven by strong cash conversion, lower capital spending and productivity measures. Free cash flow in 2026 is expected to be supported by the recent uptick in lithium prices, strong cash conversion and productivity. Its ability to convert improving operating performance into free cash is likely to result in incremental returns to shareholders. ALB expected full-year 2026 operating cash flow conversion to be within its long-term target range of 60-70% at the average lithium market price of $20 per kilogram.

The company remains focused on maintaining its dividend payout. It has raised its quarterly dividend for the 30th straight year. ALB offers a dividend yield of 0.9% at the current stock price. Backed by healthy cash flows and sound financial health, the company's dividend is perceived to be safe and reliable.

Among its peers, Sociedad Quimica y Minera de Chile S.A. (SQM - Free Report) exited the first quarter with strong liquidity, with cash and cash equivalents being around $2.8 billion. Sociedad Quimica’s solid cash position supports its capital investment in growth projects and shareholder-friendly actions. Sociedad Quimica projects total capital expenditure of $2.7 billion for the 2025-2027 period, which includes the expansion of lithium carbonate and lithium hydroxide capacity in Chile.

ICL Group Ltd. (ICL - Free Report) ended the first quarter with cash and cash equivalents, and short-term investments and deposits of $581 million. Including unutilized revolving credit facility and securitization, ICL Group had cash resources of $1,491 million at the end of the quarter. ICL generated an operating cash flow of $195 million in the first quarter. It distributed roughly $224 million in dividends to its shareholders last year.

ALB’s Price Performance, Valuation & EstimatesAlbemarle has gained 38.3% in the past six months compared with the Zacks Chemical - Diversified industry’s rise of 25.6%.

Image Source: Zacks Investment Research

ALB is currently trading at a forward price-to-sales ratio of 3.37, above the industry. It carries a Value Score of D.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for ALB’s 2026 earnings implies a year-over-year rise of 1,555.7%. The EPS estimates for 2026 have been trending higher over the past 60 days.

Image Source: Zacks Investment Research

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Let's take a look at what these Wall Street heavyweights have to say about Albemarle (ALB - Free Report) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

Albemarle currently has an average brokerage recommendation (ABR) of 1.88, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 25 brokerage firms. An ABR of 1.88 approximates between Strong Buy and Buy.

Of the 25 recommendations that derive the current ABR, 13 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 52% and 8% of all recommendations.

Brokerage Recommendation Trends for ALB

Check price target & stock forecast for Albemarle here>>>

While the ABR calls for buying Albemarle, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.

Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.

In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.

Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.

ABR Should Not Be Confused With Zacks RankAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.

The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.

In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.

In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.

There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.

Should You Invest in ALB?Looking at the earnings estimate revisions for Albemarle, the Zacks Consensus Estimate for the current year has increased 49.6% over the past month to $12.39.

Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #1 (Strong Buy) for Albemarle. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, the Buy-equivalent ABR for Albemarle may serve as a useful guide for investors.

It has been about a month since the last earnings report for Albemarle (ALB - Free Report) . Shares have lost about 16.5% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Albemarle due for a breakout? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent drivers for Albemarle Corporation before we dive into how investors and analysts have reacted as of late.

Albemarle’s Q1 Earnings and Sales Beat on Higher Lithium Pricing and VolumesAlbemarle posted a first-quarter 2026 adjusted earnings of $2.95 per share. This compares favorably with the adjusted loss of 18 cents a year ago. The figure beat the Zacks Consensus Estimate of $1.24 by 137.9%, as higher lithium pricing and improved volumes lifted results.

On a reported basis, net income attributable to Albemarle rose to $319.1 million from $41.3 million, reflecting a much stronger operating backdrop.

Net sales rose 32.7% year over year to $1.43 billion and topped the consensus mark of $1.33 billion by 7.8%. Demand indicators stayed constructive, with global Energy Storage Systems production up 117% year over year in the quarter.

Segment HighlightsEnergy Storage net sales climbed 69.9% year over year to $891.2 million, driven by higher pricing and volumes. It surpassed the consensus estimate of $775 million. Management attributed the gain to a 51% increase in price and a 14% rise in volumes versus the prior-year quarter.

Specialties net sales increased 11.7% year over year to $358.4 million. It also beat the consensus estimate of $319 million. The improvement reflected a 7% lift in volumes and a 2% increase in pricing, helped by bromine specialties demand and pricing.

Corporate and all other net sales were $179.2 million versus $231.3 million a year ago.

The divestiture of Ketjen reduced companywide net sales by 4% year over year.

FinancialsCash and cash equivalents were $1.09 billion as of March 31, 2026, compared with $1.62 billion as of Dec. 31, 2025. Long-term debt was $1.81 billion at the quarter-end, down from $3.12 billion at the end of 2025 after the company paid down $1.3 billion of outstanding debt during the quarter. Net cash provided by operating activities was $346.2 million in the first quarter of 2026 versus $547.2 million in the year-ago period.

OutlookAlbemarle updated its 2026 outlook considerations, raising the Specialties view on stronger-than-expected bromine pricing. The company now expects Specialties net sales of $1.3-$1.5 billion and adjusted EBITDA of $225-$275 million for 2026.

For the total company, Albemarle continues to frame expectations around observed lithium market price scenarios. At an average lithium market price of about $10/kg LCE, it expects net sales of $4.1-$4.3 billion and adjusted EBITDA of $0.9-$1.0 billion. At about $20/kg LCE, net sales are projected at $5.7-$6.0 billion with adjusted EBITDA of $2.4-$2.6 billion. At about $30/kg LCE, net sales are forecast at $7.5-$7.8 billion and adjusted EBITDA at $4.2-$4.4 billion.

Albemarle expects depreciation and amortization expenses of $660-$680 million for 2026. Capital expenditures are expected to be $550-$600 million, while Interest and financing expenses are forecast to be $120-$140 million for the full year.

How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates revision.

The consensus estimate has shifted 61.57% due to these changes.

VGM ScoresCurrently, Albemarle has a average Growth Score of C, however its Momentum Score is doing a bit better with a B. However, the stock was allocated a score of D on the value side, putting it in the bottom 40% for value investors.

Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Albemarle has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months.

Performance of an Industry PlayerAlbemarle is part of the Zacks Chemical - Diversified industry. Over the past month, Cabot (CBT - Free Report) , a stock from the same industry, has gained 2.2%. The company reported its results for the quarter ended March 2026 more than a month ago.

Cabot reported revenues of $904 million in the last reported quarter, representing a year-over-year change of -3.4%. EPS of $1.61 for the same period compares with $1.90 a year ago.

Cabot is expected to post earnings of $1.66 per share for the current quarter, representing a year-over-year change of -12.6%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.8%.

The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Cabot. Also, the stock has a VGM Score of A.

Albemarle (ALB - Free Report) has been beaten down lately with too much selling pressure. While the stock has lost 23.6% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.

We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.

RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.

Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.

So, by this measure, if a stock has gotten too far below its fair value just because of unwarranted selling pressure, investors may start looking for entry opportunities in the stock for benefiting from the inevitable rebound.

However, like every investing tool, RSI has its limitations, and should not be used alone for making an investment decision.

Here's Why ALB Could Experience a TurnaroundThe heavy selling of ALB shares appears to be in the process of exhausting itself, as indicated by its RSI reading of 29.81. So, the trend for the stock could reverse soon for reaching the old equilibrium of supply and demand.

This technical indicator is not the only factor that calls for a potential rebound for the stock. There is a fundamental indicator as well. A strong agreement among sell-side analysts covering ALB in raising earnings estimates for the current year has led to an increase in the consensus EPS estimate by 49.6% over the last 30 days. And an upward trend in earnings estimate revisions usually translates into price appreciation in the near term.

Moreover, ALB currently has a Zacks Rank #1 (Strong Buy), which means it is in the top 5% of more than 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. This is a more conclusive indication of the stock's potential turnaround in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Key Takeaways Albemarle's shares surged 161.9% in a year, aided by Energy Storage strength and lithium prices.ALB is expanding lithium capacity and cutting costs, with EV demand driving long-term growth.ALB focuses on cost reductions and productivity, targeting $100-$150 million in 2026 cost savings. Albemarle Corporation (ALB - Free Report) is currently trading at a forward price-to-sales ratio of 3.05, well above the Zacks Chemical - Diversified industry’s 0.95. It is also trading at a premium to its peers, Sociedad Quimica y Minera de Chile S.A. (SQM - Free Report) and Rio Tinto Group (RIO - Free Report) . Albemarle currently has a Value Score of C. Sociedad Quimica and Rio Tinto have a Value Score of B and A, respectively.

ALB’s P/S F12M Vs. Industry, SQM and RIO Image Source: Zacks Investment Research

ALB’s shares have rallied 161.9% in the past year, thanks to the strength in its Energy Storage segment and an uptick in lithium prices. ALB has outperformed the industry’s rise of 4.4% and the S&P 500’s increase of 25.2%.

ALB’s One-year Price Performance Image Source: Zacks Investment Research

ALB stock broke below its 50-day simple moving average (SMA) on May 15, 2026.  It is currently trading above its 200-day SMA, suggesting a long-term uptrend. Following a golden crossover on Sept. 3, 2025, the 50-day SMA is reading higher than the 200-day SMA, indicating a bullish trend.

Albemarle Trades Below 50-Day SMA Image Source: Zacks Investment Research

Let’s take a look at ALB’s fundamentals to analyze the stock better.

Growing Lithium Demand, Productivity & Higher Prices Aid ALBAlbemarle is well-placed to gain from long-term growth in the battery-grade lithium market. The market for lithium batteries and energy storage remains strong, especially for electric vehicles (EVs), offering significant opportunities for the company to develop innovative products and expand capacity. Lithium demand is expected to grow on the back of significant global EV penetration.

ALB expects lithium demand to witness a compound annual growth rate (CAGR) of 10-20% from 2025 to 2030. Stationary storage is expected to be a significant driver for lithium demand along with EVs. Albemarle expects demand to grow roughly 15-40% this year. Demand indicators stayed positive in the first quarter of 2026, with global Energy Storage Systems production rising 117% year over year.

The company is strategically executing its projects aimed at boosting its global lithium conversion capacity. It remains focused on investing in high-return projects to drive productivity. Healthy customer demand, capacity expansion and plant productivity improvements are supporting its volumes. ALB saw higher sales volumes (up 14% year over year) in its Energy Storage unit in the first quarter on the strength of its integrated conversion facilities.

The Salar yield improvement project in Chile has achieved a 50% operating rate, and the ramp-up continues to deliver encouraging outcomes. ALB has started the environmental permitting process for a commercial direct lithium extraction project at Salar de Atacama. The ramp-up at the Meishan lithium conversion facility in China is also progressing ahead of schedule.

Albemarle is taking aggressive cost-saving and productivity actions. The company delivered roughly $450 million in cost and productivity improvements for full-year 2025, having surpassed its initial target of $300-$400 million. It expects additional cost and productivity improvements of $100-$150 million in 2026, with $40 million already delivered this year. ALB is taking actions to maintain its competitive position, including the initiation of a comprehensive review of cost and operating structure, optimization of the conversion network and reduction of capital expenditure.

Higher lithium prices, driven by strong demand from EVs and energy storage systems, along with supply disruptions due to recent supply reductions in China, are expected to aid ALB’s performance. Lithium prices have rebounded from the trough levels seen in 2025, supported by tightening supply and strong demand in China and globally. Albemarle’s first-quarter earnings and sales topped estimates as higher lithium prices and volumes lifted results.

ALB’s Strong Financial Health Supports Capital AllocationAlbemarle remains committed to driving shareholder value by leveraging healthy cash flows and strong liquidity. Its operating cash flow was around $1.3 billion in 2025, up roughly 86% from the prior-year period. At the end of the first quarter, ALB had liquidity of around $2.7 billion, including cash and cash equivalents of around $1.1 billion. ALB generated an operating cash flow of $346 million and free cash flow of $248 million in the quarter.

The company paid down $1.3 billion of outstanding debt in March 2026, reducing annual interest expense by roughly $60 million. This followed the successful divestments of the controlling stake in Ketjen and its 50% interest in the Eurecat joint venture, which together generated $670 million in pre-tax proceeds. 
The company remains focused on maintaining its dividend payout. It has raised its quarterly dividend for the 30th straight year.

ALB offers a dividend yield of 1.1% at the current stock price. Sociedad Quimica and Rio Tinto, have a dividend yield of 3.6% and 5.1%, respectively.  

ALB’s Earnings Estimates NorthboundThe Zacks Consensus Estimate for 2026 for ALB has been revised upward over the past 60 days. The consensus estimate for second-quarter 2026 has been going up over the same time frame.

 The Zacks Consensus Estimate for 2026 earnings is currently pegged at $12.39, suggesting a year-over-year rise of 1,668.4%. Earnings are expected to increase roughly 2,700% in the second quarter.

Image Source: Zacks Investment Research

How Should Investors Play ALB Stock?Albemarle is gaining from increased lithium volumes, supported by project ramp-ups, ongoing efforts to expand its global lithium conversion capacity and productivity improvement initiatives. The company remains well-positioned to benefit from the long-term expansion of the battery-grade lithium market, driven by the accelerating adoption of EVs worldwide. Favorable lithium pricing, backed by strong demand and constrained supply, further strengthens its outlook.

Robust growth prospects and rising earnings estimates are some other positives. Although ALB trades at a premium valuation, its strong fundamentals and earnings growth potential justify the higher multiple. We advise investors to bet on this Zacks Rank #1 (Strong Buy) stock now, as it has solid growth prospects.

You can see the complete list of today’s Zacks #1 Rank stocks here.